![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
Division of Neurobiology (Y.-P.K., L.X., J.B.E., R.J.L.) and Neurology (L.Z., J.W.), Barrow Neurological Institute, Phoenix, Arizona
To evaluate possible physiological roles of the large cytoplasmic loops (C2) and neighboring transmembrane domains of nicotinic acetylcholine receptor (nAChR) subunits, we generated novel fusion constructs in which human nAChR
4,
2, or
4 subunit C2 or C2 and neighboring sequences were replaced by corresponding sequences from the mouse serotonin type 3A (5-HT3A) receptor subunit. Following stable expression in human SH-EP1 cells, we found that extensive sequence substitutions involving third and fourth transmembrane domains and neighboring "proximal" C2 sequences (e.g.,
2 H322-V335 and V449-R460) did not allow functional expression of nAChR containing chimeric subunits. However, expression of functional nAChR was achieved containing wild-type
4 subunits and chimeric
2 (
2
) subunits whose "nested" C2 domain sequences K336-S448 were replaced with the corresponding 5-HT3A subunit sequences. Whereas these findings suggested indispensable roles for M3/M4 transmembrane and/or proximal C2 sequences in
4
2-nAChR function, nested C2 sequences in the
2 subunit are not essential for functional receptor expression. Ligand-binding analyses also revealed only subtle differences in pharmacological profiles of
4
2-nAChR compared with
4
2
-nAChR. Nevertheless, there was heightened emergence of agonist-mediated self-inhibition of
4
2
function, greater sensitivity to functional blockade by a number of antagonists, and faster and more complete acute desensitization of
4
2
-nAChR than for
4
2-nAChR. These studies are consistent with unexpected roles of nested C2 sequences in nAChR function.
Address correspondence to: Dr. Yen-Ping Kuo, Department of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013. E-mail: ykuo{at}chw.edu.
This article has been cited by other articles:
![]() |
J. E. Carland, M. A. Cooper, S. Sugiharto, H.-J. Jeong, T. M. Lewis, P. H. Barry, J. A. Peters, J. J. Lambert, and A. J. Moorhouse Characterization of the Effects of Charged Residues in the Intracellular Loop on Ion Permeation in {alpha}1 Glycine Receptor Channels J. Biol. Chem., January 23, 2009; 284(4): 2023 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function Physiol Rev, January 1, 2009; 89(1): 73 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zwart, A. L. Carbone, M. Moroni, I. Bermudez, A. J. Mogg, E. A. Folly, L. M. Broad, A. C. Williams, D. Zhang, C. Ding, et al. Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant {alpha}4{beta}2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., June 1, 2008; 73(6): 1838 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wu, Q. Liu, K. Yu, J. Hu, Y.-P. Kuo, M. Segerberg, P. A. St John, and R. J. Lukas Roles of nicotinic acetylcholine receptor {beta} subunits in function of human {alpha}4-containing nicotinic receptors J. Physiol., October 1, 2006; 576(1): 103 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Briggs, E. J. Gubbins, M. J. Marks, C. B. Putman, R. Thimmapaya, M. D. Meyer, and C. S. Surowy Untranslated Region-Dependent Exclusive Expression of High-Sensitivity Subforms of {alpha}4beta2 and {alpha}3beta2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., July 1, 2006; 70(1): 227 - 240. [Abstract] [Full Text] [PDF] |
||||